What Treatment Reduces Cardiac Risk in Hyperthyroidism? What Treatment Reduces Cardiac Risk in Hyperthyroidism?
Patients with hyperthyroidism had a lower risk for deadly cardiovascular events after surgery or radioactive iodine than those with ATDs, found a national cohort study.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 10, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Novo Nordisk's Stock Could Get Another Boost, Thanks to This Huge Development
Novo Nordisk (NYSE: NVO) has become one of the most valuable healthcare stocks in the world, largely due to a couple of exceptional drugs, Ozempic and Wegovy. While the former is a diabetes drug and the latter is approved for weight loss, consumers have been using both to help lose weight. And…#novonordisk #nvo #ozempicandwegovy #wegovyformedicare #cvshealth #kaiserpermanente #medicare #fda #wegovy #denmark (Source: Reuters: Health)
Source: Reuters: Health - April 10, 2024 Category: Consumer Health News Source Type: news
Is taking statins making my diabetes worse? Dr Rosemary Leonard reveals answer
A reader with type-2 diabetes is no longer able to control her blood sugar through diet alone and asks the Express GP if statins may be the reason for this (Source: Daily Express - Health)
Source: Daily Express - Health - April 10, 2024 Category: Consumer Health News Source Type: news
Ozempic, Wegovy Won't Boost Thyroid Cancer Risk: Study
WEDNESDAY, April 10, 2024 -- Wegovy, Ozempic and other drugs known as GLP-1 analogues have become wildly popular for controlling diabetes and helping folks lose weight.
There were concerns that longer term use of the drugs might raise users ' odds... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 10, 2024 Category: General Medicine Source Type: news
Dr Michael Mosley shares 'best single way' to lose weight and live longer
This easy at-home style of exercise could even boost heart health and slash your risk for diabetes, according to the top doctor. (Source: Daily Express - Health)
Source: Daily Express - Health - April 10, 2024 Category: Consumer Health News Source Type: news
Scientists at UT Health San Antonio Discover New Biomarker for Diabetic Kidney Disease
Biomarker may lead to clinical laboratory testing that enables clinical pathologists and urologists to diagnose risk for diabetic kidney failure years before it occurs Clinical laboratories working with nephrologists and urologists to diagnose patients experiencing urinary system difficulties know that albumin (excessive protein found in the urine) is a common biomarker used in clinical laboratory […]
The post Scientists at UT Health San Antonio Discover New Biomarker for Diabetic Kidney Disease appeared first on Dark Daily. (Source: Dark Daily)
Source: Dark Daily - April 10, 2024 Category: Laboratory Medicine Authors: Jillia Schlingman Tags: Laboratory Instruments & Laboratory Equipment Laboratory News Laboratory Pathology Laboratory Resources Laboratory Testing adenine albumin anatomic pathology biomarker clinical laboratory clinical pathology Dark Daily dark intellig Source Type: news
Let more NHS staff work flexibly to help solve staffing crisis
NHS managers should do more to allow staff to work in flexible ways, including having more control over shift patterns or doing compressed hours*, says UNISON today (Wednesday).
Data from a new UNISON survey** shows a significant proportion of healthcare workers are not being given the alternative work patterns they’ve asked for.
The survey found two-thirds (65%) of women employed in healthcare across the UK who’ve asked for different work arrangements had their requests agreed in full.
But more than one in five (22%) were unable to obtain flexible working. A further one in eight (13%) had their requests ini...
Source: UNISON meat hygiene - April 10, 2024 Category: Food Science Authors: Anthony Barnes Tags: News Press release 2024 National Health Conference flexible working NHS staff Source Type: news
Managing Obesity: More Than GLP-1s or Bust Managing Obesity: More Than GLP-1s or Bust
Obesity expert Dr Holly Lofton reviews three alternatives to GLP-1s to help patients drop excess weight.Medscape Internal Medicine (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 9, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Commentary Source Type: news
Want 'natural' Ozempic? Try eating your veggies BEFORE your meat - experts say it triggers the same anti-hunger effects as the drug
Eating veggies, then meat, then protein may help your body process your meals food more slowly, similarly to how the wonder-drug Ozempic works. This might help people with diabetes especially, experts say. (Source: the Mail online | Health)
Source: the Mail online | Health - April 9, 2024 Category: Consumer Health News Source Type: news
America ’ s Growing Birthweight Crisis
Americans are increasingly at risk of having lower incomes, poorer health, and a worse shot at opportunity even before they are born. More babies are now born with low birthweights than in the last 30 years. This has caused growing inequalities that can persist if not properly addressed. In certain parts of the country, that risk may be ten-times greater.
Underweight newborns are at an increased risk of long term health challenges, lower IQ scores, and developmental delays. New data shows that the frequency of this problem is rising with more than 300,000 newborns now experiencing low birthweight. This public hea...
Source: TIME: Health - April 9, 2024 Category: Consumer Health News Authors: Jeremy Ney Tags: Uncategorized freelance Source Type: news
ACC: Semaglutide Beneficial in Obesity-Related Heart Failure, Type 2 Diabetes
TUESDAY, April 9, 2024 -- Semaglutide leads to larger reductions in heart failure-related symptoms and physical limitations among patients with obesity-related heart failure with preserved ejection fraction and type 2 diabetes, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 9, 2024 Category: Pharmaceuticals Source Type: news
Delhi High Court seeks response from govt, NPPA on Glenmark's plea
Delhi High Court hears Glenmark Pharma's petition against NPPA's pricing order for anti-diabetic drugs, claiming arbitrary pricing and seeking exemption due to DCGI approval. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 9, 2024 Category: Pharmaceuticals Source Type: news
Young Adults May Soon Be Able to Get an RSV Shot
Pfizer Inc.’s RSV shot produced immune reactions in young adults at higher risk of severe illness just as well as in older people, spurring the company’s plans to apply for wider U.S. approval.
A single dose of the vaccine, called Abrysvo, produced a strong immune response in adults ages 18 to 59 with conditions such as asthma, diabetes, or chronic lung disease, Pfizer said. Based on the final-stage trial results, the company plans to ask the Food and Drug Administration to extend the shot’s approval to adults 18 and older.
[time-brightcove not-tgx=”true”]
RSV, or respiratory syncytial ...
Source: TIME: Health - April 9, 2024 Category: Consumer Health News Authors: Madison Muller and Robert Langreth/Bloomberg Tags: Uncategorized healthscienceclimate wire Source Type: news
What Experts Really Think About Diet Soda
Growing up, Olivia Dreizen Howell, 39, “lived on” diet soda. So did her family. At a family reunion in 1996, everyone sported T-shirts with their shared surname in Diet Coke-can font. “We drank Diet Coke, Diet ginger ale, and Diet Sprite like water—there was no difference in our household,” she says.
Like many, Howell believed that sugar-free soda was a benign choice. But the latest research casts doubt on that assumption, linking diet drinks to mood disorders, fatty liver development, autoimmune diseases, and cancer, to name a few.
[time-brightcove not-tgx=”true”]
Bef...
Source: TIME: Health - April 9, 2024 Category: Consumer Health News Authors: Perri Ormont Blumberg Tags: Uncategorized Evergreen freelance healthscienceclimate Source Type: news
Wegovy Helps Those With Both Diabetes, Heart Failure: Study
TUESDAY, April 9, 2024 -- For people struggling with both diabetes and a common type of heart failure, the weight-loss drug Wegovy may do more for their health than help them shed pounds, new research suggests.
In the study, published Saturday in... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 9, 2024 Category: General Medicine Source Type: news
